A single subcutaneous injection provides 5 days of CINV protection1,2

SUSTOL was designed to offer lasting CINV prevention1,2

  • SUSTOL is supplied as a refrigerated kit with a single-dose, sterile, pre-filled glass syringe that contains 10 mg of granisetron/0.4 mL*1
  • SUSTOL should be administered at least 30 minutes before chemotherapy1,3
  • Store SUSTOL in the refrigerator at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE1
  • SUSTOL may be left out at room temperature overnight, and for up to 7 days, before it must be discarded. SUSTOL may be re-refrigerated if not used within the 7-day period1,3
  • Protect from light1
Items included in the SUSTOL kit
*Each product package contains SUSTOL Prescribing Information, Medication Guide, and Instructions for Use.
View IFU
Please review all Instructions for Use (IFU) included with the medication prior to administration.

One convenient kit allows for administration with 3 basic steps

SUSTOL administration step 1

READY SUSTOL by removing from refrigeration and unpacking kit at least 60 minutes prior to administration to allow SUSTOL and the warming pouches to reach room temperature.3

SUSTOL administration step 2

WARM SUSTOL to body temperature by wrapping assembled syringe in activated warming pouch for 5-6 minutes. Do NOT remove blue needle cover.3

SUSTOL administration step 3

INJECT SUSTOL subcutaneously in upper arm or abdomen using a firm and steady push. Pressing plunger harder will not expel SUSTOL faster.3

To help facilitate administration, SUSTOL must be at body temperature immediately prior to injection3
CINV=chemotherapy-induced nausea and vomiting.

References:

  1. SUSTOL [prescribing information]. Heron Therapeutics, Inc., 2023.
  2. Ottoboni, et al. J Exp Pharmacol. 2014.
  3. SUSTOL [instructions for use]. Heron Therapeutics, Inc., 2017.
  4. Schnadig, et al. Future Oncol. 2016.
  5. Zhou, et al. Ther Clin Risk Manag. 2015.